Edgewise Therapeutics, Inc. (EWTX) Tops Q2 EPS by 8c

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q2 EPS of ($0.34), $0.08 better than the analyst estimate of ($0.42).

For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.

You May Also Be Interested In

• Meta to pay up to $16.68 billion in mass social media settlement
• Medical Care Technologies (OTC PINK:MDCE) Advances AI Longitudinal Body-Map Monitoring Capabilities Within its Melanoma Scan Beta App
• Cleantek Industries Secures Sale of HALO SE Units for Deployment in Alaska